Biotechnology Market Reports

Kalorama Information is your trusted source for market research on the biotechnology industry. Reports provide key industry trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with biotech industry leaders to provide keen insights into consumer and institutional trends.

<< prev 1 2 3 4 5 next >>

Title	Published	Price
Trends in Cell Therapeutics: Promise and Reality Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem  |  more... Buy by the section | Search inside this report	Mar 1, 2004	$3,500.00
Drug Delivery Technology and Applications: A summary of Kalorama's market research, 2001-2003 Over the past three years, Kalorama Information's analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and  |  more... Search inside this report	Nov 7, 2003	$746.00
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$2,995.00
Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets In 2003, the market for monoclonal antibodies in the treatment of cancer is just short of $2.8 billion and growing at a phenomenal rate. The market is fueled by leading products such as Rituxan and Herceptin; however, other products continue to demand more attention each year. This study  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$3,500.00
Molecular Nanotechnology in Medicine: A Market Briefing Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer  |  more... Search inside this report	Sep 1, 2004	$895.00
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed. Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number  |  more... Buy by the section | Search inside this report	Jun 1, 2005	$3,500.00
Wound Care Markets, 2nd Edition, Vol I: Skin Ulcers The aging of the population and continued advances in biotechnology drive the skin ulcer portion of the wound care industry, estimated at $3.3 billion globally. A lack of effective treatment options has heretofore added to the increased costs of skin ulcer treatment and has contributed to the growing frustration in  |  more... Buy by the section | Search inside this report	Jul 1, 2005	$2,995.00
Wound Care Markets, 2nd Edition, Vol II: Burns Approximately 27 million burn cases requiring professional treatment occur worldwide each year, and of these 7 million will require hospitalization and more than a million will die as a direct result of their burns. Burn injuries are a particularly difficult and painful area of medicine requiring multi-pronged approach to address  |  more... Buy by the section | Search inside this report	Aug 1, 2005	$2,995.00
Wound Care Markets, 2nd Edition, Vol III: Surgical and Trauma Wounds Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area, but it is by no means the easiest to compete in. There are millions of surgical procedures performed annually worldwide; in the United States alone, there are over 100,000 surgeries performed  |  more... Buy by the section | Search inside this report	Sep 1, 2005	$2,995.00
The Future of Biotechnology Instrumentation The field of biotechnology instrumentation has been an expanding one ever since the emergence of the Human Genome Project 20 years ago. Although the filed certainly existed prior to that point in time, it was the Human Genome Project with its major access to key universities, national laboratories, and  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
The Protein Therapeutics Market: The Science and Business of a Growing Sector The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to  |  more... Buy by the section | Search inside this report	Jun 1, 2006	$995.00
The Emerging Cancer Vaccine Market, 2nd Edition Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama’s groundbreaking 2003 study completely updates the market data and reviews the technological, clinical, and business trends that have shaped and reshaped this emerging field. Specific segments covered  |  more... Buy by the section | Search inside this report	Nov 1, 2006	$1,200.00
Early Toxicology: Markets and Approaches Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient  |  more... Search inside this report	Jun 1, 2007	$2,800.00
Orthopedic Biomaterials, The World Market, 2nd Edition Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials used in orthopedic surgery include autografts, allografts, xenografts, ceramics, polymers, bone growth factors and synovial  |  more... Search inside this report	Sep 1, 2007	$1,995.00
Wound Care, 3rd Edition, Vol. II: Burns The aging of the population and continued advances in biotechnology drive the multi-billion dollar wound care industry globally. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial  |  more... Search inside this report	Sep 1, 2007	$2,995.00
SNP Genotyping and Analysis Markets SNPs (single nucleotide polymorphisms), single base pair mutations that occur at a specific site in the DNA sequence, are the most common type of genetic variation between human beings. Because they are responsible for over 80% of the variation between two individuals, SNPs are ideal for the task  |  more... Search inside this report	Jun 1, 2008	$3,995.00
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and  |  more... Search inside this report	May 1, 2007	$995.00
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.) Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems. This provides an opportunity for BRIC countries and other developing regions to grab  |  more... Buy by the section | Search inside this report	Nov 1, 2007	$2,800.00
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine) This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a  |  more... Search inside this report	Jun 1, 2008	$2,995.00
The Market for Vaccines This report details the most recent product approvals and developments in the vaccines market. Find out the latest in the development of single-dose and combined vaccines, and DNA vaccines. The report analyzes the trends shaping the future of  |  more... Buy by the section | Search inside this report	Feb 1, 2000	$2,112.00
The Market for Nutraceuticals Nutraceuticals, or foods that deliver therapeutic or preventative health benefits, are by all accounts, poised to explode. Kalorama Information's new report provides an unprecedented determination of current and potential sales of nutraceutical foods and beverages; analyzes factors that  |  more... Buy by the section | Search inside this report	Apr 1, 1998	$2,437.50
Market For Cancer Diagnostics According to this Kalorama Information report, oncogenes and anti-oncogenes may well provide unique and feasible test kits for early, accurate detection making an even greater impact on the market in years ahead. All aspects of this important area are detailed here: the new products, industry mergers, the regulatory environment,  |  more... Search inside this report	Apr 1, 1996	$1,625.00
Market for Bioremediation Products and Services Based on extensive research, and interviews with leading executives in the field, this report from Kalorama Information takes a close look at bioremediation products and services, their technologies, and applications. Factors highlighted include bioremediation methods and processes, the regulatory and legislative environment, alternative remediation cost/benefit comparisons, potential sites for bioremediation,  |  more... Search inside this report	Sep 1, 1995	$1,625.00
Market for Antiviral Therapeutics and Vaccines This report from Kalorama Information examines the burgeoning antiviral market, and provides a comprehensive analysis of both therapeutics and vaccines: AIDS and HIV therapeutics; hepatitis therapeutics and vaccines; influenza therapeutics and vaccines; mumps, measles, and rubella vaccines; polio vaccines; respiratory syncytial virus therapeutics; and products used to treat rare diseases.  |  more... Search inside this report	Jan 1, 1996	$1,625.00
MarketLooks: The U.S. Market for Wound Closure Products MarketLooks are concise, graphic-rich summaries of full-length market research reports. Reports that cover more than one market segment are split into corresponding MarketLooks to allow you to purchase only what you need. All MarketLooks are created in PowerPoint(R) for easy extraction of text, charts and tables for  |  more...	Jun 1, 1999	$299.00
Title	Published	Price

<< prev 1 2 3 4 5 next >>